Abstract
A novel self-delivered prodrug system was fabricated for tumor-targeting therapy. In this nanosystem, the Arg-Gly-Asp-Ser (RGDS) tetrapeptide was used to improve the therapeutic index to integrin-overexpressing tumor cells. The antitumorous drug camptothecin was further appended to the ε-amino group of lysine by 20-O-succinyl linkage and controllably released via hydrolytic cleavage. Prodrug molecules self-assembled into fibrillar nano-architectures and achieved the capability of self-delivery after being injected subcutaneously into mice. Introduction of hydrophobic myristic acid favored the self-assembly and enhanced the cellular internalization of the prodrugs. In vitro and in vivo studies demonstrated that the self-assembled nanofibers could effectively target integrinoverexpressing tumorous cells and inhibit tumor growth via RGD-mediated specific targeting. Therefore, the traditional idea that fibrillar structures hold low therapeutic efficacy due to poor cell uptake can be challenged.
Similar content being viewed by others
References
Allen, T. M.; Cullis, P. R. Liposomal drug delivery systems: From concept to clinical applications. Adv. Drug Deliv. Rev. 2013, 65, 36–48.
Ding, J. X.; Chen, L. H.; Xiao, C. S.; Chen, L.; Zhuang, X. L.; Chen, X. S. Noncovalent interaction-assisted polymeric micelles for controlled drug delivery. Chem. Commun. 2014, 50, 11274–11290.
Yu, J. M.; Xie, X.; Xu, X. Y.; Zhang, L.; Zhou, X. Y.; Yu, H.; Wu, P.; Wang, T.; Che, X. X.; Hu, Z. H. Development of dual ligand-targeted polymeric micelles as drug carriers for cancer therapy in vitro and in vivo. J. Mater. Chem. B 2014, 2, 2114–2126.
Zhang, J.; Yuan, Z. F.; Wang, Y.; Chen, W. H.; Luo, G. F.; Cheng, S. X.; Zhuo, R. X.; Zhang, X. Z. Multifunctional envelope-type mesoporous silica nanoparticles for tumortriggered targeting drug delivery. J. Am. Chem. Soc. 2013, 135, 5068–5073.
Liang, R. Z.; Wei, M.; Evans, D. G.; Duan, X. Inorganic nanomaterials for bioimaging, targeted drug delivery and therapeutics. Chem. Commun. 2014, 50, 14071–14081.
Li, Z. Y.; Hu, J. J.; Xu, Q.; Chen, S.; Jia, H. Z.; Sun, Y. X.; Zhuo, R. X.; Zhang, X. Z. A redox-responsive drug delivery system based on RGD containing peptide-capped mesoporous silica nanoparticles. J. Mater. Chem. B 2015, 3, 39–44.
Xiang, X.; Ding, X. C.; Moser, T.; Gao, Q.; Shokuhfar, T.; Heiden, P. A. Peptide-directed self-assembly of functionalized polymeric nanoparticles. Part II: Effects of nanoparticle composition on assembly behavior and multiple drug loading ability. Macromol. Biosci. 2015, 15, 568–582.
Xiao, D.; Jia, H. Z.; Ma, N.; Zhuo, R. X.; Zhang, X. Z. A redox-responsive mesoporous silica nanoparticle capped with amphiphilic peptides by self-assembly for cancer targeting drug delivery. Nanoscale 2015, 7, 10071–10077.
Shen, Y. Q.; Jin, E. L.; Zhang, B.; Murphy, C. J.; Sui, M. H.; Zhao, J.; Wang, J. Q.; Tang, J. B.; Fan, M. H.; van Kirk, E. et al. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J. Am. Chem. Soc. 2010, 132, 4259–4265.
Huttunen, K. M.; Raunio, H.; Rautio, J. Prodrugs-from serendipity to rational design. Pharmacol. Rev. 2011, 63, 750–771.
Bui, D. T.; Maksimenko, A.; Desmaële, D.; Harrisson, S.; Vauthier, C.; Couvreur, P.; Nicolas, J. Polymer prodrug nanoparticles based on naturally occurring isoprenoid for anticancer therapy. Biomacromolecules 2013, 14, 2837–2847.
Yuan, Y. Y.; Kwok, R. T. K.; Tang, B. Z.; Liu, B. Targeted theranostic platinum(IV) prodrug with a built-in aggregationinduced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ. J. Am. Chem. Soc. 2014, 136, 2546–2554.
Chen, W. H.; Luo, G. F.; Lei, Q.; Jia, H. Z.; Hong, S.; Wang, Q. R.; Zhuo, R. X.; Zhang, X. Z. MMP-2 responsive polymeric micelles for cancer-targeted intracellular drug delivery. Chem. Commun. 2015, 51, 465–468.
Cheetham, A. G.; Zhang, P. C.; Lin, Y. A.; Lock, L. L.; Cui, H. G. Supramolecular nanostructures formed by anticancer drug assembly. J. Am. Chem. Soc. 2013, 135, 2907–2910.
Li, S. Y.; Liu, L. H.; Jia, H. Z.; Qiu, W. X.; Rong, L.; Cheng, H.; Zhang, X. Z. A pH-responsive prodrug for real-time drug release monitoring and targeted cancer therapy. Chem. Commun. 2014, 50, 11852–11855.
Huang, P.; Wang, D. L.; Su, Y.; Huang, W.; Zhou, Y. F.; Cui, D. X.; Zhu, X. Y.; Yan, D. Y. Combination of small molecule prodrug and nanodrug delivery: Amphiphilic drug–drug conjugate for cancer therapy. J. Am. Chem. Soc. 2014, 136, 11748–11756.
Zhang, T.; Huang, P.; Shi, L. L.; Su, Y.; Zhou, L. Z.; Zhu, X. Y.; Yan, D. Y. Self-assembled nanoparticles of amphiphilic twin drug from floxuridine and bendamustine for cancer therapy. Mol. Pharmaceutics 2015, 12, 2328–2336.
Standley, S. M.; Toft, D. J.; Cheng, H.; Soukasene, S.; Chen, J.; Raja, S. M.; Band, V.; Band, H.; Cryns, V. L.; Stupp, S. I. Induction of cancer cell death by self-assembling nanostructures incorporating a cytotoxic peptide. Cancer Res. 2010, 70, 3020–3026.
Jiang, X.; Qu, W.; Pan, D.; Ren, Y.; Williford, J. M.; Cui, H. G.; Luijten, E.; Mao H. Q. Plasmid-templated shape control of condensed DNA-block copolymer nanoparticles. Adv. Mater. 2013, 25, 227–232.
Kim, S. H.; Kaplan, J. A.; Sun, Y.; Shieh, A.; Sun, H. L.; Croce, C. M.; Grinstaff, M. W.; Parquette, J. R. The selfassembly of anticancer camptothecin-dipeptide nanotubes: A minimalistic and high drug loading approach to increased efficacy. Chem.—Eur. J. 2015, 21, 101–105.
Garlich, J. R.; De, P.; Dey, N.; Su, J. D.; Peng, X. D.; Miller, A.; Murali, R.; Lu, Y. L.; Mills, G. B.; Kundra, V. et al. A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity. Cancer Res. 2008, 68, 206–215.
Fairbanks, B. D.; Schwartz, M. P.; Halevi, A. E.; Nuttelman, C. R.; Bowman, C. N.; Anseth, K. S. A versatile synthetic extracellular matrix mimic via thiol-norbornene photopolymerization. Adv. Mater. 2009, 21, 5005–5010.
Qin, S. Y.; Jiang, H. F.; Peng, M. Y.; Lei, Q.; Zhuo, R. X.; Zhang, X. Z. Adjustable nanofibers self-assembled from an irregular conformational peptide amphiphile. Polym. Chem. 2015, 6, 519–524.
Das, P.; Jana, N. R. Dopamine functionalized polymeric nanoparticle for targeted drug delivery. RSC Adv. 2015, 5, 33586–33594.
Cheng, H.; Cheng, Y. J.; Bhasin, S.; Zhu, J. Y.; Xu, X. D.; Zhuo, R. X.; Zhang, X. Z. Complementary hydrogen bonding interaction triggered co-assembly of an amphiphilic peptide and an anti-tumor drug. Chem. Commun. 2015, 51, 6936–6939.
Cui, H. G.; Webber, M. J.; Stupp, S. I. Self-assembly of peptide amphiphiles: From molecules to nanostructures to biomaterials. Biopolymers 2010, 94, 1–18.
Nabiev, I.; Fleury, F.; Kudelina, I.; Pommier, Y.; Charton, F.; Riou, J. F.; Alix, A. J. P.; Manfait, M. Spectroscopic and biochemical characterisation of self-aggregates formed by antitumor drugs of the camptothecin family. Biochem. Pharmacol. 1998, 55, 1163–1174.
Qin, S. Y.; Peng, M. Y.; Rong, L.; Li, B.; Wang, S. B.; Cheng, S. X.; Zhuo, R. X.; Zhang, X. Z. Self-defensive nano-assemblies from camptothecin-based antitumor drugs. Regen. Biomat. 2015, 2, 159–166.
Yang, Z. M.; Liang, G. L.; Xu, B. Supramolecular hydrogels based on β-amino acid derivatives. Chem. Commun. 2006, (7), 738–740.
Qin, S. Y.; Pei, Y.; Liu, X. J.; Zhuo, R. X.; Zhang, X. Z. Hierarchical self-assembly of β-amyloid peptide derivative. J. Mater. Chem. B 2013, 1, 668–675.
Lee, M. H.; Kim, J. Y.; Han, J. H.; Bhuniya, S.; Sessler, J. L.; Kang, C.; Kim. J. S. Direct fluorescence monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended naphthalimide theragnostic prodrug. J. Am. Chem. Soc. 2012, 134, 12668–12674.
Oussoren, C.; Storm, G. Liposomes to target the lymphatics by subcutaneous administration. Adv. Drug Deliv. Rev. 2001, 50, 143–156.
Lee, H.; Yu, M. K.; Park, S.; Moon, S.; Min, J. J.; Jeong, Y. Y.; Kang, H.-W.; Jon, S. Thermally cross-linked superparamagnetic iron oxide nanoparticles: Synthesis and application as a dual imaging probe for cancer in vivo. J. Am. Chem. Soc. 2007, 129, 12739–12745.
Koo, O. M. Y.; Rubinstein, I.; Önyüksel, H. Actively targeted low-dose camptothecin as a safe, long-acting, diseasemodifying nanomedicine for rheumatoid arthritis. Pharm. Res. 2011, 28, 776–787.
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Peng, M., Qin, S., Jia, H. et al. Self-delivery of a peptide-based prodrug for tumor-targeting therapy. Nano Res. 9, 663–673 (2016). https://doi.org/10.1007/s12274-015-0945-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12274-015-0945-1